Cargando…

Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109

Detalles Bibliográficos
Autores principales: Bůžková, Petra, Barzilay, Joshua I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609946/
https://www.ncbi.nlm.nih.gov/pubmed/31110124
http://dx.doi.org/10.2337/dc19-0204
_version_ 1783432415052562432
author Bůžková, Petra
Barzilay, Joshua I.
author_facet Bůžková, Petra
Barzilay, Joshua I.
author_sort Bůžková, Petra
collection PubMed
description
format Online
Article
Text
id pubmed-6609946
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-66099462020-06-01 Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109 Bůžková, Petra Barzilay, Joshua I. Diabetes Care e-Letters: Comments and Responses American Diabetes Association 2019-06 2019-05-10 /pmc/articles/PMC6609946/ /pubmed/31110124 http://dx.doi.org/10.2337/dc19-0204 Text en © 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Comments and Responses
Bůžková, Petra
Barzilay, Joshua I.
Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title_full Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title_fullStr Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title_full_unstemmed Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title_short Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
title_sort comment on davis et al. development and validation of a simple hip fracture risk prediction tool for type 2 diabetes: the fremantle diabetes study phase i. diabetes care 2018;42:102–109
topic e-Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609946/
https://www.ncbi.nlm.nih.gov/pubmed/31110124
http://dx.doi.org/10.2337/dc19-0204
work_keys_str_mv AT buzkovapetra commentondavisetaldevelopmentandvalidationofasimplehipfractureriskpredictiontoolfortype2diabetesthefremantlediabetesstudyphaseidiabetescare201842102109
AT barzilayjoshuai commentondavisetaldevelopmentandvalidationofasimplehipfractureriskpredictiontoolfortype2diabetesthefremantlediabetesstudyphaseidiabetescare201842102109